Thank you for Subscribing to Life Science Review Weekly Brief
Conversational AI is becoming more sophisticated to the point that it can increasingly fill gaps and assist individuals who need someone to chat to.
Fremont, CA: Loneliness is frequently caused or exacerbated by a lack of social connections. Nothing beats talking to a friend or family member to alleviate loneliness. However, this is not always achievable. Conversational AI is becoming more sophisticated, to the point that it can increasingly cover gaps and assist individuals who need to communicate with someone.
The healthcare industry is ready for a variety of conversational AI application cases. These technologies, when used correctly, have the potential to have a huge influence on our lives and the medical world. A few countries have already begun to use conversational AI on a big basis to improve their healthcare services. Loneliness is a major public health problem that significantly raises morbidity and death risks. Robots embodied conversational agents, and chatbots are examples of artificial agents found to lessen patient loneliness by offering social support. However, just like a doctor-patient interaction, the quality of a patient's connection with an artificial agent can influence support effectiveness and care engagement.
Incorporating mammalian attachment-building behavior as part of an agent's skills may increase relationship quality and engagement between patients and artificial agents.
With misinformation and uncertainty regarding COVID-19 rising, meaningful patient involvement is becoming increasingly important. According to research, engaged people have better health outcomes, and effective technologies improve service delivery. However, it's not always as easier as just communicating more. Communicating with impact is the true key, and innovators and suppliers are working hard to figure out the best methods.
mPulse Mobile and Magellan Rx Management are two such groups that have recently cooperated to combat social isolation and loneliness in approximately 1,800 persons with chronic and specialized disorders across the United States. The firms claim that by utilizing mPulse's conversational AI technology, they could hold text-message discussions with participants on many health-related topics over the course of 45 days.